In March 2020, an expert panel called the Front Line COVID-19 Critical Care Alliance (FLCCC) was created and led by Professor Paul E. Marik, with the goal of continuously reviewing the rapidly emerging basic science, translational, and clinical data in order to gain insight into and to develop a treatment protocol for COVID-19. At the…
Video: Ivermectin and COVID-19 by Dr Martin Gill, December 22, 2020
Dr Martin Gill outlines the current research on Ivermectin and its implications for the treatment of Covid-19 in Africa.
South African National Department of Health recommends Ivermectin for further clinical trials
In a “rapid review” of Ivermectin for Covid-19 the South African National Department of Health recommended that eligible patients with Covid‐19 in South Africa should be considered for enrolment in relevant therapeutic trials, but did not endorse the drug for general treatment of Covid-19 patients. “The evidence of efficacy and safety is very uncertain at…
FLCCC Alliance issues one-page summary of clinical trials showing large magnitude improvements in COVID-19 patients treated with Ivermectin
Newswise — NEW YORK, NEW YORK: December 21, 2020— The Frontline COVID-19 Critical Care Alliance (FLCCC) has released a one-page summary of the most up-to-date clinical trials evidence supporting the use of ivermectin in the treatment of all stages of COVID-19—from prevention to serious illness. Their comprehensive scientific review manuscript of all the referenced clinical trials can be found on the Open…
Dr John Campbell: Ivermectin and COVID 19
A summary of current findings from Dr John Campbell.
Video: Dr Pierre Kory testifies to senate committee about I-MASK+ protocol on 8 December 2020
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly…
FLCCC Alliance Calls on National Health Authorities to Immediately Review Medical Evidence Showing the Efficacy of Ivermectin for the Prevention of COVID-19 and as an Early Outpatient Treatment
Newswise — “Following the swift review— and subsequent guidance— by the NIH and the CDC of Ivermectin, we expect that Ivermectin’s widespread, immediate use will allow for a rapid and safe re-opening of businesses and schools across the nation—and quickly reduce the strain on overwhelmed ICUs.” —FLCCC Alliance HOUSTON, TEXAS—DECEMBER 4, 2020:—At a press conference…